InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: None

Wednesday, 04/23/2014 8:36:30 PM

Wednesday, April 23, 2014 8:36:30 PM

Post# of 345605

Lung cancer set to catch breast cancer as the deadliest cancer amongst women

April 24, 2014


Lung cancer will overtake breast cancer as the biggest cancer killer among women “within the next few years”, leading experts have said, as more women who began smoking in the 1960s and 1970s succumb to the disease in old age.

Across Europe, lung cancer in women, and pancreatic cancer in both men and women, are now the only types for which mortality rates continue to rise.

The mortality rate for lung cancer among women in the 27 EU states will rise by eight per cent in 2014, while the number of breast cancer deaths falls by nine per cent, according to a new international study published today .

Researchers at the University of Milan and Lausanne Hospital in Switzerland project that the trends will continue, with lung cancer likely to become the biggest cause of cancer death among women by the end of the decade.

Overall, cancer deaths have reduced by 26 per cent among men and by 20 per cent in women over the past 25 years, thanks to improved treatments and quicker diagnosis from screening programmes and imaging technology.

However, the delayed impact of widespread changes in the demographic of European smokers, which saw large numbers of women take up smoking in the 1960s and 1970s, means that lung cancer in women is bucking the trend as these same women reach their 60s and 70s, when people are most likely to develop lung cancer.

Pancreatic cancer is the only other type for which mortality rates continue to rise, for both men and women. Pancreatic cancer has few symptoms in its early stages and is often diagnosed too late for any treatments to be effective. It has the lowest survival rates of the 22 most common cancers.

http://www.independent.co.uk/life-style/health-and-families/health-news/lung-cancer-set-to-catch-breast-cancer-as-the-deadliest-cancer-amongst-women-9278516.html


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News